当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析

智飞生物

(300122)

  

流通市值:714.80亿  总市值:1207.68亿
流通股本:14.21亿   总股本:24.00亿

智飞生物(300122)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润65.30亿元,每股收益2.72元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2996653.59万元,未分配利润2671857.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产4927216.72万元,负债1930563.13万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入39,271,716,845.2124,445,313,338.8511,172,773,125.4538,264,011,331.74
营业总成本31,146,168,101.4619,160,755,294.298,596,876,197.8529,049,844,276.08
营业利润7,635,847,800.024,967,447,560.22,396,874,549.598,758,380,180.77
利润总额7,619,073,617.384,962,334,956.42,392,289,272.358,718,007,864.78
净利润6,530,323,266.834,259,927,399.092,032,024,553.167,538,999,697.34
其他综合收益----
综合收益总额6,530,323,266.834,259,927,399.092,032,024,553.167,538,999,697.34
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计42,066,348,094.4840,907,529,076.6536,415,229,618.9331,413,362,556.7
非流动资产合计7,205,819,062.326,952,981,566.166,827,199,136.386,590,371,385.25
资产总计49,272,167,156.847,860,510,642.8143,242,428,755.3138,003,733,941.95
流动负债合计18,638,843,279.6819,489,439,559.4116,363,591,587.2413,230,005,564.86
非流动负债合计666,788,001.12674,931,075.14610,600,005.74537,515,767.92
负债合计19,305,631,280.820,164,370,634.5516,974,191,592.9813,767,521,332.78
归属于母公司股东权益合计29,966,535,87627,696,140,008.2626,268,237,162.3324,236,212,609.17
股东权益合计29,966,535,87627,696,140,008.2626,268,237,162.3324,236,212,609.17
负债和股东权益合计49,272,167,156.847,860,510,642.8143,242,428,755.3138,003,733,941.95
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计32,084,245,278.619,671,449,821.958,213,422,139.531,370,285,593.4
经营活动现金流出小计29,498,411,777.617,494,401,510.49,253,450,970.7329,381,252,488.14
经营活动产生的现金流量净额2,585,833,5012,177,048,311.55-1,040,028,831.231,989,033,105.26
投资活动现金流入小计150,370,264.32759,175729,175646,784.96
投资活动现金流出小计819,695,003.79562,560,265.11270,977,272.241,498,601,683.66
投资活动产生的现金流量净额-669,324,739.47-561,801,090.11-270,248,097.24-1,497,954,898.7
筹资活动现金流入小计6,122,796,383.093,128,359,293.092,866,915,531.745,516,548,948.79
筹资活动现金流出小计7,754,136,750.453,988,930,569.791,375,193,627.587,689,196,338.38
筹资活动产生的现金流量净额-1,631,340,367.36-860,571,276.71,491,721,904.16-2,172,647,389.59
汇率变动对现金及现金等价物的影响-1,008,716.81-354,047.57-5,284,002.8917,557,289.07
现金及现金等价物净增加额284,159,677.36754,321,897.17176,160,972.8-1,664,011,893.96
期末现金及现金等价物余额2,899,848,528.73,370,010,748.512,791,849,824.142,615,688,851.34
最新报告期:2024-02-23
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国盛证券张金洋3.835.016.262024-02-23
国盛证券张金洋3.835.016.252024-02-23
中金公司张琎,杨一正3.634.625.452024-02-19
中金公司张琎,杨一正3.634.625.452024-02-19
国盛证券张金洋3.835.016.262024-02-18
TOP↑